Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
Orion to receive an upfront payment of USD 290 million
Novavax’ clinical development program reported no severe allergic reactions
Philips demonstrates portfolio of smart connected imaging systems and integrated radiology workflow solutions designed to improve diagnostic confidence and clinical outcomes
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
An algorithm based testing for Fatty Liver Disease
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
The combined company will be able to better serve both our global and regional customers with local production
Subscribe To Our Newsletter & Stay Updated